Work

Mitigating Paxlovid™-induced drug‒drug interaction toxicity: an in silico insight

Year: 2024
Type: article
Abstract: The clinical drug-drug interaction side-effects of Ritonavir, an ingredient in Paxlovid™, have been documented, highlighting the need to explore alternative administration methods for Nirmatrelvir, another drug in the Paxlovid™ combination. In this study, the skin permeability potential of Nirmatrelvir was assessed using various in silico models. The prediction results suggest that Nirmatrelvir could be administrated via the transdermal route, offering a promising avenue to enhance the efficacy of anti-COVID-19 agents.
Language: English
Open Access status: gold
Estimated APC paid: $3,295
OpenAlex ID: W4404730215
FWCI: 0.201
Cites: 18
Cited by: 1
Related to: 10